ATE347371T1 - Zusammenstellungen zur erhöhung der darmabsoption von fetten - Google Patents

Zusammenstellungen zur erhöhung der darmabsoption von fetten

Info

Publication number
ATE347371T1
ATE347371T1 AT99944090T AT99944090T ATE347371T1 AT E347371 T1 ATE347371 T1 AT E347371T1 AT 99944090 T AT99944090 T AT 99944090T AT 99944090 T AT99944090 T AT 99944090T AT E347371 T1 ATE347371 T1 AT E347371T1
Authority
AT
Austria
Prior art keywords
absoption
fat
compositions
increase intestinal
intestine
Prior art date
Application number
AT99944090T
Other languages
English (en)
Inventor
David W Yesair
Original Assignee
Biomolecular Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomolecular Products Inc filed Critical Biomolecular Products Inc
Application granted granted Critical
Publication of ATE347371T1 publication Critical patent/ATE347371T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/683Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/465Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y301/00Hydrolases acting on ester bonds (3.1)
    • C12Y301/01Carboxylic ester hydrolases (3.1.1)
    • C12Y301/01004Phospholipase A2 (3.1.1.4)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT99944090T 1998-09-08 1999-09-07 Zusammenstellungen zur erhöhung der darmabsoption von fetten ATE347371T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9943098P 1998-09-08 1998-09-08

Publications (1)

Publication Number Publication Date
ATE347371T1 true ATE347371T1 (de) 2006-12-15

Family

ID=22274976

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99944090T ATE347371T1 (de) 1998-09-08 1999-09-07 Zusammenstellungen zur erhöhung der darmabsoption von fetten

Country Status (13)

Country Link
US (1) US6426069B1 (de)
EP (1) EP1119360B1 (de)
JP (1) JP4700193B2 (de)
CN (1) CN1321089A (de)
AT (1) ATE347371T1 (de)
AU (1) AU771901B2 (de)
CA (1) CA2343116C (de)
DE (1) DE69934325T2 (de)
IL (2) IL141801A0 (de)
NO (1) NO20011173L (de)
NZ (1) NZ510536A (de)
WO (1) WO2000013689A1 (de)
ZA (1) ZA200102268B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1434593B1 (de) * 2001-10-11 2017-03-29 Biomolecular Products, Inc. MODIFIKATIONEN FESTER 3-sn-PHOSPHOGLYCERIDE
ES2355890T3 (es) 2002-04-05 2011-04-01 Societe des Produits Nestlé S.A. Composiciones y métodos para promocionar la asimilación de lípidos en los animales domésticos.
DE10217555A1 (de) * 2002-04-19 2004-02-19 Degussa Bioactives Deutschland Gmbh Physiologisch verträgliche, Phospholipid-haltige, stabile und harte Matrix
PT1594544T (pt) * 2003-01-31 2016-07-14 Los Angeles Childrens Hospital Composições orais de fenretinida tendo biodisponibilidade aumentada e métodos de utilização das mesmas
US7758884B2 (en) * 2005-01-28 2010-07-20 Kemin Industries, Inc. Formulation for increasing the deposition of dietary carotenoids in eggs
EP1688049A1 (de) * 2005-02-03 2006-08-09 findusFit Sportdiätetika GmbH Diätetisches Lebensmittel
FR2918846B1 (fr) * 2007-07-20 2013-07-26 Isl Innovation Sante Lipides Composition alimentaire pour ameliorer la digestibilite des lipides alimentaires
WO2012053306A1 (ja) * 2010-10-22 2012-04-26 学校法人 福岡大学 胃上皮性腫瘍(腺腫・胃癌)の診断に有用な白色不透明物質を応用した内視鏡観察法および診断能改善組成物
WO2012068169A2 (en) * 2010-11-15 2012-05-24 Texas Tech University Substance for increasing the production of a specific acyl-chain dihydroceramide(s) for improving the effectiveness of cancer treatments
AU2019342421B2 (en) * 2018-09-21 2024-09-05 Société des Produits Nestlé S.A. Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)
WO2025148196A1 (zh) * 2024-01-12 2025-07-17 小藻科技(安吉)有限公司 一种促进脂肪酸吸收及跨越血脑屏障的微藻提取物及其组合物的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4874795A (en) 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
US4849132A (en) 1986-05-16 1989-07-18 Asahi Denka Kogyo Kabushiki Kaisha Surfactant composition having improved functions
DE69109297T2 (de) * 1990-08-13 1995-11-09 David W. Byfield Mass. Yesair Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.
US5571517A (en) 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
JPH08143469A (ja) * 1994-11-14 1996-06-04 Amano Pharmaceut Co Ltd 膵外分泌機能不全症治療剤
DE69614855T2 (de) * 1995-06-06 2002-03-28 Biomolecular Products, Inc. Gemischte lipid-bicarbonat kolloidale partikel zur abgabe von arzneistoffen oder kalorien
US5716814A (en) 1996-02-02 1998-02-10 Biomolecular Products, Inc. Methods for making lysophosphatidylcholine
ES2329529T3 (es) * 1996-09-11 2009-11-26 Elizabeth Shanahan-Prendergast Formulaciones terapeuticas que contienen veneno de serpiente y/o de insecto para la profilaxis y la terapia del neoplasma.

Also Published As

Publication number Publication date
AU5705299A (en) 2000-03-27
US6426069B1 (en) 2002-07-30
JP2002524417A (ja) 2002-08-06
AU771901B2 (en) 2004-04-08
WO2000013689A1 (en) 2000-03-16
EP1119360A4 (de) 2003-06-04
CA2343116C (en) 2008-11-18
DE69934325T2 (de) 2007-07-05
NZ510536A (en) 2003-07-25
NO20011173L (no) 2001-05-08
NO20011173D0 (no) 2001-03-07
DE69934325D1 (de) 2007-01-18
EP1119360B1 (de) 2006-12-06
ZA200102268B (en) 2001-09-19
IL141801A (en) 2009-02-11
CN1321089A (zh) 2001-11-07
JP4700193B2 (ja) 2011-06-15
EP1119360A1 (de) 2001-08-01
CA2343116A1 (en) 2000-03-16
IL141801A0 (en) 2002-03-10

Similar Documents

Publication Publication Date Title
BR9809793A (pt) Monoésteres de probucol para o tratamento de doença inflamatória e cardiovascular
IL138476A0 (en) Method for treating pharmaceutical compositions by special use of anti-oxidant
BR9915679A (pt) Composições e métodos para aumentar a mineralização óssea
TR200000927T2 (tr) Prostaglandin agonistleri ve kemik bozukluklarının tedavisi
DE59800221D1 (de) Verfahren zur Stabilisierung von Retinol bzw. Retinol-Derivaten
ATE247666T1 (de) Wasserlöslische prodrugs von 2,6- diisopropylphenol-analoga
FI973496L (fi) Fosfolipidipitoinen stabiloitu kaasuemulsio ultraäänikontrastin parantamiseen
DK1663185T3 (da) Forebyggelse og behandling af inflammationsinduceret og/eller immun-medieret knogletab
BR9914044A (pt) ésteres tetrahidropirido
DE69531403D1 (de) Allosterische modulatoren des nmda-rezeptors
DE69909325D1 (de) Fliessfähige gasblasen enthaltende wasser-in-öl-emulsionen
AP9801269A0 (en) Prostaglandin agonists.
DE69934325D1 (de) Zusammenstellungen zur erhöhung der darmabsoption von fetten
ECSP034442A (es) Mezclas de polisacaridos derivados de la heparina, su preparacion y las composiciones farmaceuticas que las contienen
DE69635304D1 (de) Faenger fuer oxidantien
DE69821300D1 (de) Verfahren zur Herstellung alkoholstabiler (Mikro-) Emulsionen
ES2156105T3 (es) Derivados de amino-fenoles sustituidos en n y o, productos intermedios para su preparacion, su utilizacion como substratos para hidrolasas, un correspondiente procedimiento de determinacion y un agente de diagnostico apropiado para ello.
DK0977871T3 (da) Neurotrypsin
ATE247101T1 (de) Benzothiophenderivate, zwischenprodukte, verfahren, zubereitungen und methoden
DE59900916D1 (de) Verfahren zur Herstellung von 4-Aminodiphenylamin
ES2163634T3 (es) Benzopiranos y composiciones farmaceuticas que les contienen.
BRPI0405791A (pt) Preparados de metal nobre e preparados de lustrina para a serigrafia direta e indireta
NO20005548L (no) Mykobakterieinhibitorer
DE69830351D1 (de) Verfahren zur Herstellung von Siloxanzusammensetzungen
DE60016951D1 (de) Zellulosefilme zur durchfuehrung von screening-verfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties